Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Aug 1;317(7154):329-32.
doi: 10.1136/bmj.317.7154.329.

Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology

Affiliations
Review

Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology

Z E Hopkinson et al. BMJ. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Probable mechanisms whereby defects in insulin metabolism promote increased androgen activity at the level of the ovary
Figure 2
Figure 2
Central role of insulin resistance in both the clinical presenting features and long term sequelae of polycystic ovarian syndrome

Comment in

References

    1. Frank S. Polycystic ovary syndrome. N Engl J Med. 1995;333:853–861. - PubMed
    1. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, et al. Coronary heart disease risk factors in women with polycystic ovarian syndrome. Arterioscler Thromb Vasc Biol. 1995;15:821–826. - PubMed
    1. Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective study of women. Acta Obstet Gynecol Scand. 1992;71:599–604. - PubMed
    1. Conway G, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary heart disease in lean and obese women with PCOS. Clin Endocrinol. 1992;37:119–125. - PubMed
    1. Dunaif A. Insulin resistance and the polycystic ovarian syndrome: mechanisms and implications for pathogenesis. Endocr Rev. 1997;18:774–800. - PubMed

Publication types

MeSH terms